Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 16:25:41 UTC |
---|
Update Date | 2021-09-26 23:11:35 UTC |
---|
HMDB ID | HMDB0256127 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Parecoxib |
---|
Description | Parecoxib, also known as SC 69124, belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Parecoxib is a drug which is used for short term perioperative pain control. Based on a literature review a significant number of articles have been published on Parecoxib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Parecoxib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Parecoxib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1 InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22) |
---|
Synonyms | Value | Source |
---|
N-((p-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide | ChEBI | Parecoxibum | ChEBI | SC 69124 | ChEBI | SC-69124 | ChEBI | N-((p-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl)sulphonyl)propionamide | Generator | N-(((5-Methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt | MeSH | Parecoxib sodium | MeSH | N-(((5-Methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamide | MeSH | Dynastat | MeSH | N-(((Me-P)-P)S)P | MeSH |
|
---|
Chemical Formula | C19H18N2O4S |
---|
Average Molecular Weight | 370.422 |
---|
Monoisotopic Molecular Weight | 370.098727764 |
---|
IUPAC Name | N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonyl]propanamide |
---|
Traditional Name | parecoxib |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22) |
---|
InChI Key | TZRHLKRLEZJVIJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzenesulfonamides |
---|
Direct Parent | Benzenesulfonamides |
---|
Alternative Parents | |
---|
Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Azole
- Isoxazole
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Heteroaromatic compound
- Sulfonyl
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Parecoxib,1TMS,isomer #1 | CCC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 3066.5 | Semi standard non polar | 33892256 | Parecoxib,1TMS,isomer #1 | CCC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 3104.1 | Standard non polar | 33892256 | Parecoxib,1TMS,isomer #1 | CCC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 4333.8 | Standard polar | 33892256 | Parecoxib,1TBDMS,isomer #1 | CCC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 3315.5 | Semi standard non polar | 33892256 | Parecoxib,1TBDMS,isomer #1 | CCC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 3325.4 | Standard non polar | 33892256 | Parecoxib,1TBDMS,isomer #1 | CCC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 | 4261.3 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Parecoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-055b-5093000000-db3e92926f485c400d54 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Parecoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Parecoxib 35V, Negative-QTOF | splash10-014i-0469000000-f6052003554a020d0609 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Parecoxib 35V, Positive-QTOF | splash10-00di-0986000000-520dd33eedc4a686c413 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 10V, Positive-QTOF | splash10-00di-1019000000-c728be169067b0126d0d | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 20V, Positive-QTOF | splash10-0zos-5059000000-f83fbece820e78e5eca2 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 40V, Positive-QTOF | splash10-0adi-8590000000-1c37127a53aae762e8de | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 10V, Negative-QTOF | splash10-014i-0009000000-0b3df646b995c3d571fc | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 20V, Negative-QTOF | splash10-014j-2149000000-55191fcdfab63c7101c6 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Parecoxib 40V, Negative-QTOF | splash10-0f6x-7981000000-a4c6679d347cfe9d27c1 | 2017-07-26 | Wishart Lab | View Spectrum |
|
---|